Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

ALZN

Alzamend Neuro Inc

Apr 02 • 04:00PM ET

1.04

Dollar change +0.04
Percentage change 4.51	%

Healthcare • Biotechnology • USA • NASD

Peers: AMGN LLY MRK ABBV AZN BMY BIIB REGN VRTX GILD

| Held by: VXF

Index	-	P/E	-	EPS (ttm)	-3.06	Insider Own	4.42%	Shs Outstand	6.61M	Perf Week	4.00%
Market Cap	6.87M	Forward P/E	-	EPS next Y	-1.22	Insider Trans	9.90%	Shs Float	6.32M	Perf Month	43.45%
Income	-4.23M	PEG	-	EPS next Q	-0.38	Inst Own	1.71%	Short Float	1.91%	Perf Quarter	-13.33%
Sales	0.00M	P/S	-	EPS this Y	89.05%	Inst Trans	50.78%	Short Ratio	0.32	Perf Half Y	-38.46%
Book/sh	0.60	P/B	1.75	EPS next Y	24.22%	ROA	-168.13%	Short Interest	0.12M	Perf Year	-88.18%
Cash/sh	0.51	P/C	2.04	EPS next 5Y	61.95%	ROE	-1092.96%	52W Range	0.64 - 15.06	Perf YTD	-10.34%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-11.45%	ROI	-122.53%	52W High	-93.09%	Beta	-0.20
Dividend TTM	-	Quick Ratio	5.44	Sales past 5Y	0.00%	Gross Margin	-	52W Low	61.82%	ATR (14)	0.09
Dividend Ex-Date	-	Current Ratio	5.44	EPS Y/Y TTM	83.62%	Oper. Margin	-	RSI (14)	58.06	Volatility	9.60% 10.42%
Employees	7	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	2.00	Target Price	20.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	95.01%	Payout	-	Rel Volume	0.37	Prev Close	1.00
Sales Surprise	-	EPS Surprise	0.00%	Sales Q/Q	-	Earnings	Mar 13	Avg Volume	381.17K	Price	1.04
SMA20	16.39%	SMA50	6.34%	SMA200	-45.36%	Trades		Volume	139,707	Change	4.51%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-01-21	Initiated	Ascendiant Capital Markets	Buy	$8

Mar-28-25 10:42AM	Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March? (Insider Monkey)
Mar-25-25 08:00AM	Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer's Disease to take Place at Massachusetts General Hospital (GlobeNewswire)
Mar-18-25 08:00AM	Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital (GlobeNewswire) +5.03%
Mar-11-25 08:00AM	Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital (GlobeNewswire)
Mar-04-25 08:10AM	Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital (GlobeNewswire)
08:00AM	Loading…
Feb-25-25 08:00AM	Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital (GlobeNewswire)
07:30AM	EXCLUSIVE: Alzamend Neuro To Start First Phase 2 Study For Lead Candidate In 2025 (Benzinga)
Feb-19-25 08:00AM	Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital (Business Wire) -6.48%
07:30AM	EXCLUSIVE: Alzamend Neuro Says Tesla Dynamic Completes Head Coil To Measure Brain Structure Lithium Levels (Benzinga)
Jan-23-25 09:40AM	Has Alzamend Neuro (ALZN) Outpaced Other Medical Stocks This Year? (Zacks)
Jan-15-25 08:00AM	Alzamend Neuro to Present at the Sequire Investor Summit (Business Wire)
Dec-18-24 08:00AM	Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo (Business Wire)
Dec-13-24 08:15AM	Alzamend Neuro says net cash gained by financing activity $8.3M (TipRanks)
Dec-12-24 08:00AM	Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs (Business Wire)
Nov-19-24 08:00AM	Alzamend Neuro Announces Full Data Set from its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimers Transgenic Mice (Business Wire)
07:30AM	Loading…
07:30AM	EXCLUSIVE: Alzamend Neuro Reveals Full Data From Nonclinical Study Of Its Lead Alzheimer's Drug Potential (Benzinga)
Oct-16-24 08:00AM	Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimers (Business Wire)
07:30AM	EXCLUSIVE: Alzamend Neuro Reveals Full Data Set From Multiple Ascending Dose Trial For Lead Candidate For Dementia Related to Alzheimer's (Benzinga)
Oct-15-24 08:00AM	Alzamend Neuro Regains Compliance with Nasdaq Listing Standards (Business Wire)
Oct-10-24 08:00AM	Alzamend Neuro CEO Stephan Jackman to Participate in the Maxim Groups Virtual Healthcare Conference (Business Wire)
Aug-26-24 08:00AM	Alzamend Neuro Issues Letter to Stockholders (Business Wire) -7.47%
Aug-19-24 08:00AM	Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a NextGeneration Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder (Business Wire) +186.78%
Aug-12-24 08:00AM	Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a NextGeneration Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder (Business Wire)
Aug-06-24 08:00AM	Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a NextGeneration Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder (Business Wire) -9.84%
05:32AM	Alzamend Neuro partners with Mass General for Alzheimers treatment trial (Clinical Trials Arena)
Aug-05-24 09:09AM	Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Alzheimers Disease (Business Wire) -22.09%
07:30AM	EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study (Benzinga)
Jul-31-24 08:00AM	Alzamend Neuro Regains Compliance with Nasdaqs Minimum Bid Price Requirement (Business Wire)
Jul-12-24 08:00AM	Alzamend Neuro Announces Reverse Stock Split (Business Wire)
May-22-24 08:00AM	Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel (Business Wire)
08:00AM	Loading…
May-14-24 08:00AM	Alzamend Neuro Announces Initial Closing of Private Placement (Business Wire) +18.81%
May-09-24 09:30AM	EXCLUSIVE: Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares (Benzinga) +11.74%
08:00AM	Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million (Business Wire)
May-07-24 08:00AM	Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program (Business Wire) -20.02%
Apr-02-24 05:41PM	Insiders Are Buying These 11 Penny Stocks (Insider Monkey)
Mar-26-24 05:52AM	ALZN Stock Earnings: Alzamend Neuro Misses EPS for Q3 2024 (InvestorPlace)
Dec-18-23 12:03PM	ALZN Stock Earnings: Alzamend Neuro Reported Results for Q2 2024 (InvestorPlace)
12:03PM	ALZN Stock Earnings: Alzamend Neuro Beats EPS for Q1 2024 (InvestorPlace)
Dec-11-23 09:30AM	EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year (Benzinga) -6.54%
08:00AM	Alzamend Neuro Receives FDA Study May Proceed Notification for a Phase IIA Clinical Trial of AL001, a NextGeneration Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients (Business Wire)
Nov-20-23 08:00AM	Alzamend Neuro Receives FDA Study May Proceed Notification for a Phase IIA Clinical Trial of AL001, a NextGeneration Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients (Business Wire) -17.75%
Nov-16-23 08:00AM	Alzamend Neuro Regains Compliance with Nasdaqs Minimum Bid Price Requirement (Business Wire)
Nov-13-23 08:00AM	Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of NextGeneration Lithium Therapeutic Drug Candidate AL001 (Business Wire) -6.85%
Oct-30-23 08:00AM	Alzamend Neuro Announces Reverse Stock Split (Business Wire) -24.62%
Oct-23-23 09:31AM	EXCLUSIVE: Alzamend Neuro Submits IND For Phase IIA Trial Of Next-Gen Lithium Candidate In Major Depressive Disorder (Benzinga)
08:00AM	Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Major Depressive Disorder Patients of its NextGeneration Lithium Therapeutic Drug Candidate AL001 (Business Wire)
Oct-02-23 09:30AM	EXCLUSIVE: Alzamend Neuro To Start Next-Gen Therapy Study For Bipolar Disorder (Benzinga) -8.48%
08:00AM	Alzamend Neuro Receives FDA Study May Proceed Notification for a Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, in Bipolar Disorder Patients (Business Wire)
Sep-22-23 08:00AM	Alzamend Neuro Granted Extension by Nasdaq Panel to Regain Compliance with the Minimum Bid Price Continued Listing Requirement (Business Wire)
Aug-30-23 09:30AM	EXCLUSIVE: Alzamend Seeks FDA Approval For Study For Upgraded Version Of Most Commonly Used Treatment For Bipolar Disorder (Benzinga)
08:00AM	Alzamend Neuro Submits IND Application for Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, in Bipolar Disorder Patients (Business Wire)
Jun-22-23 09:30AM	EXCLUSIVE: Alzamend Neuro Identifies Potential AL001 Dose Level For Upcoming Alzheimer's Study (Benzinga)
08:00AM	Alzamend Neuro Announces Positive Phase IIA Clinical Trial Results for AL001 (Business Wire)
Jun-13-23 08:00AM	Alzamend Neuro CEO Stephan Jackman to Participate on the "Mental Health, More Critical Than Ever" Panel at the Maxim Groups Virtual Healthcare Conference (Business Wire)
May-24-23 08:00AM	3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024 (InvestorPlace) +10.30%
May-11-23 12:38PM	3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year (InvestorPlace)
Apr-04-23 06:30AM	Ault Alliance Announces Alzamend Neuro Has Initiated Its Phase I/IIA Trial for Its Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimers Type (Business Wire)
Apr-03-23 09:35AM	KILL Alzamend Neuro Receives FDA "Study May Proceed" Letter for Phase I/IIA Trial Under Its Investigational New Drug Application for an Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimers Type (Business Wire) +15.29%
09:34AM	EXCLUSIVE: Alzamend Neuro Starts Phase 1/2A Trial For Its Alzheimer's Immunotherapy Vaccine (Benzinga)
08:50AM	Alzamend Neuro Announces the Initiation of a Phase I/IIA Trial for Its Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimers Type (Business Wire)
Mar-22-23 09:30AM	EXCLUSIVE: Alzamend Neuro Completes Clinical Portion Of Mid-Stage Alzheimer's Trial (Benzinga)
08:00AM	Alzamend Neuro Announces Completion of Clinical Portion of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimers (Business Wire)
Mar-17-23 07:09AM	We Think Alzamend Neuro (NASDAQ:ALZN) Needs To Drive Business Growth Carefully (Simply Wall St.) -12.36%
Mar-16-23 08:00AM	Alzamend Neuro Reports Third Fiscal Quarter Financial Results and Provides a Business Update (Business Wire)
Jan-26-23 08:00AM	Alzamend Neuro to Present at Sequire Biotechnology Conference (Business Wire) +9.48%
Jan-04-23 08:00AM	Alzamend Neuro Partners With Biorasi to Conduct a First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase I/IIA Clinical Trial (Business Wire)
Dec-28-22 08:00AM	Alzamend Neuro Partners With the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for ALZN002 Phase I/IIA Immunotherapy Vaccine Clinical Trial to Treat Mild to Moderate Dementia of the Alzheimers Type (Business Wire) -11.31%
07:31AM	EXCLUSIVE: Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia (Benzinga)
Dec-13-22 03:52PM	10 Biotech Stocks With The Biggest Upside (Insider Monkey)
Nov-22-22 08:05AM	In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Stephan Jackman, CEO Alzamend Neuro, Inc. (ACCESSWIRE) +10.62%
Nov-15-22 08:00AM	Alzamend Neuro CEO Stephan Jackman to Appear on Fox Business Network to Discuss Therapeutic Pipeline (Business Wire)
Oct-31-22 08:00AM	Alzamend Neuro Receives FDA "Study May Proceed" Letter for Phase I/IIA Trial Under Its Investigational New Drug Application for an Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimers Type (Business Wire)
Oct-11-22 10:03AM	Alzamend Neuro, Inc.'s (NASDAQ:ALZN) top owners are individual investors with 46% stake, while 21% is held by private companies (Simply Wall St.) -11.19%
Oct-05-22 12:45PM	Alzamend Neuro Adds Healthy Subjects to Ongoing Mid-Stage Alzheimer's Trial (Benzinga) +7.25%
08:00AM	Alzamend Neuro Announces Addition of Healthy Subjects to Ongoing Phase IIA Clinical Trial for AL001 in Alzheimers Subjects (Business Wire)
Sep-29-22 12:29PM	Alzamend Neuro Seeks FDA Nod For Dementia Immunotherapy Study (Benzinga)
08:00AM	Alzamend Neuro Submits IND Application for Phase I/IIA Trial for an Immunotherapy (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimers Type (Business Wire)
Sep-22-22 08:00AM	Alzamend Neuro Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement (Business Wire) -7.63%
Aug-25-22 07:13AM	We Think Alzamend Neuro (NASDAQ:ALZN) Can Afford To Drive Business Growth (Simply Wall St.)
Jul-24-22 08:41AM	6 Penny Stocks With 1,000% Upside Potential (InvestorPlace)
Jul-18-22 10:42AM	Alzamend Neuro Receives Positive FDA Response For Its Depression Candidate (Benzinga)
08:00AM	Alzamend Neuro Receives Positive Pre-IND Response from FDA for AL001 Treatment of Bipolar Disorder, Major Depressive Disorder and Post-Traumatic Stress Disorder (Business Wire)
Jun-20-22 09:22AM	10 Best Biotech Penny Stocks To Buy Now (Insider Monkey)
Jun-03-22 08:00AM	Alzamend Neuro to Present at the 12th Annual LD Micro Invitational (Business Wire)
May-17-22 08:00AM	Alzamend Neuro Announces Pre-IND Submission for AL001 as a Treatment of Bipolar Disorder, Major Depressive Disorder and Post-Traumatic Stress Disorder (Business Wire) +7.25%
May-06-22 09:02AM	10 Biotech Penny Stocks Redditors Love (Insider Monkey) -6.74%
May-05-22 08:00AM	Alzamend Neuro Announces Initiation of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimers (Business Wire)
May-04-22 06:25AM	What Kind Of Investors Own Most Of Alzamend Neuro, Inc. (NASDAQ:ALZN)? (Simply Wall St.)
Apr-28-22 06:30AM	BitNile Holdings Announces Additional Investment in Alzamend From Completion of Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimers (Business Wire)
06:30AM	Alzamend Neuro Announces $4 Million Additional Investment from Digital Power Lending Upon Completion of Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimers (Business Wire)
Apr-11-22 08:00AM	Alzamend Neuro Contracts with Altasciences and iResearch Atlanta to Manage and Conduct Its Phase IIA Study in Patients with Alzheimers (Business Wire) -6.25%
Apr-06-22 10:15AM	10 Biotech Penny Stocks with Growth Catalysts (Insider Monkey)
Apr-04-22 08:00AM	Alzamend Neuro Appoints Dr. Terri Hunter to Its Scientific Advisory Board (Business Wire)
Mar-28-22 08:00AM	Alzamend Neuro Announces Full Data Set From Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimers (Business Wire)
Mar-18-22 06:31AM	We're Hopeful That Alzamend Neuro (NASDAQ:ALZN) Will Use Its Cash Wisely (Simply Wall St.) +9.71%
Jan-13-22 04:00AM	ALZN: Coordinated Offensive on Alzheimers Disease (Zacks Small Cap Research)
Dec-17-21 09:54AM	Alzamend Neuro Shares Are Trading Higher After Encourage Early-Stage Data From Alzheimer's Candidate (Benzinga)
09:00AM	Alzamend Neuro Announces Positive Topline Data from Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimers (Business Wire)
Dec-14-21 06:35PM	Why Alzamend Neuro Stock Soared Today (Motley Fool) +28.33% -15.91%
11:18AM	MIND Stock: The U.S. Navy Deal That Has Mind Technology Shares Surging Today (InvestorPlace)

Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Atlanta, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Horne William B.	Director	Mar 26 '25	Buy	0.99	3,334	3,285	30,000	Mar 27 07:30 AM
AULT MILTON C III	Director	Mar 21 '25	Buy	1.02	2,905	2,969	85,273	Mar 25 04:30 PM
Katzoff David J	Chief Financial Officer	Mar 21 '25	Buy	1.01	5,000	5,048	5,540	Mar 24 07:30 AM
Horne William B.	Director	Mar 20 '25	Buy	0.98	5,000	4,892	26,666	Mar 20 04:30 PM
Horne William B.	Director	Mar 18 '25	Option Exercise	0.06	10,000	600	16,666	Mar 19 04:30 PM
Horne William B.	Director	Mar 18 '25	Buy	0.97	5,000	4,852	21,666	Mar 19 04:30 PM
AULT MILTON C III	Director	Mar 18 '25	Buy	0.96	5,000	4,810	82,368	Mar 18 07:12 PM
AULT MILTON C III	Director	Mar 12 '25	Buy	0.68	100	68	77,368	Mar 14 05:30 PM
AULT MILTON C III	Director	Aug 06 '24	Buy	2.75	75	206	77,268	Aug 14 06:01 PM
AULT MILTON C III	Director	Jul 31 '24	Buy	3.74	25	93	77,193	Aug 01 05:20 PM
AULT MILTON C III	Director	Apr 19 '24	Buy	0.69	1,000	688	771,699	Apr 23 08:00 PM

Dollar change +0.37
Percentage change 15.77	%

GPUS Hyperscale Data Inc daily Stock Chart

Peers: AMT CCI EQIX DLR SBAC COR IRM GDS BWXT CIA

Index	-	P/E	-	EPS (ttm)	-843.57	Insider Own	12.60%	Shs Outstand	1.11M	Perf Week	7.20%
Market Cap	3.38M	Forward P/E	-	EPS next Y	-	Insider Trans	3.64%	Shs Float	1.10M	Perf Month	-11.26%
Income	-159.99M	PEG	-	EPS next Q	-	Inst Own	2.44%	Short Float	14.20%	Perf Quarter	-47.86%
Sales	140.91M	P/S	0.02	EPS this Y	-	Inst Trans	0.39%	Short Ratio	2.08	Perf Half Y	-66.66%
Book/sh	2.46	P/B	1.09	EPS next Y	-	ROA	-47.96%	Short Interest	0.16M	Perf Year	-78.71%
Cash/sh	24.52	P/C	0.11	EPS next 5Y	-	ROE	-316.96%	52W Range	2.17 - 20.26	Perf YTD	-44.86%
Dividend Est.	-	P/FCF	-	EPS past 5Y	84.21%	ROI	-511.48%	52W High	-86.78%	Beta	3.35
Dividend TTM	-	Quick Ratio	0.22	Sales past 5Y	-	Gross Margin	21.08%	52W Low	23.50%	ATR (14)	0.31
Dividend Ex-Date	-	Current Ratio	0.23	EPS Y/Y TTM	99.49%	Oper. Margin	-42.13%	RSI (14)	49.46	Volatility	14.45% 10.78%
Employees	-	Debt/Eq	46.75	Sales Y/Y TTM	-12.43%	Profit Margin	-113.54%	Recom	1.00	Target Price	356752.71
Option/Short	No / Yes	LT Debt/Eq	10.46	EPS Q/Q	99.29%	Payout	-	Rel Volume	1.12	Prev Close	2.32
Sales Surprise	-8.67%	EPS Surprise	-	Sales Q/Q	-35.24%	Earnings	-	Avg Volume	75.20K	Price	2.68
SMA20	9.48%	SMA50	-16.64%	SMA200	-58.70%	Trades		Volume	84,243	Change	15.77%

Apr-02-25 06:30AM	Hyperscale Data Announces 56 Bitcoin Mined Year to Date and 3,061 Bitcoin Mined Since Inception of Mining Operations in March 2021 (GlobeNewswire) +15.77%
Apr-01-25 06:30AM	Hyperscale Data Enters into an Agreement for up to $50 Million in New Equity Financing to Accelerate Buildout of Artificial Intelligence Data Center in Michigan (GlobeNewswire)
Mar-31-25 03:39PM	Is Hyperscale Data, Inc. (GPUS) Among the Worst Performing Defense Stocks So Far in 2025? (Insider Monkey) -8.61%
02:09PM	Why Hyperscale Data, Inc. (GPUS) Is Gaining This Week? (Insider Monkey)
06:30AM	Hyperscale Data to Recognize One Time Gain of Approximately $17.5 Million in Q1 2025 (GlobeNewswire)
06:30AM	Loading…
Mar-28-25 06:30AM	Hyperscale Data Completes First Installation of Nvidia GPUs for HPC Customer (GlobeNewswire) -7.04%
Mar-20-25 06:30AM	Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (GlobeNewswire)
Mar-05-25 06:30AM	Hyperscale Data, Inc. Announces Acceptance of Plan by NYSE (GlobeNewswire)
Mar-03-25 06:30AM	Hyperscale Data, Inc. Announces Preliminary 2024 Results: $108.8 Million in Revenue, $150.3 Million Pro Forma with Giga-tronics (GlobeNewswire)
Feb-27-25 06:30AM	Hyperscale Data Subsidiary Reaches Agreement in Principle to Add Capability for an Incremental 40 Megawatts to its Michigan Data Center, Boosting AI Infrastructure Development (GlobeNewswire) -5.09%
Feb-24-25 06:30AM	Hyperscale Data Engages Northland Capital Markets to Explore Strategic Options for Michigan Data Center (GlobeNewswire) +15.16%
Feb-19-25 06:30AM	Hyperscale Data Subsidiary Reaches Agreement in Principle with Key Utility to Expand Michigan Data Center to 300 Megawatts, which Would Allow the Company to Advance its AI Infrastructure Growth (GlobeNewswire)
Feb-18-25 06:30AM	Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (GlobeNewswire)
Feb-12-25 06:30AM	Hyperscale Data Announces 32 Consecutive Monthly Cash Dividend Payments Timely Paid for Series D Cumulative Redeemable Perpetual Preferred Stock (GlobeNewswire)
Feb-07-25 06:30AM	Hyperscale Data Announces 19.2 Bitcoin Mined in January 2025 (GlobeNewswire)
06:30AM	Loading…
Jan-28-25 06:30AM	Hyperscale Data Announces 31 Consecutive Monthly Cash Dividend Payments Timely Paid for Series D Cumulative Redeemable Perpetual Preferred Stock (GlobeNewswire)
Jan-17-25 06:30AM	Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (GlobeNewswire) +25.67%
Jan-07-25 06:30AM	Ault & Company, Inc. Announces an Increased Majority Stake in Hyperscale Data, Inc. (GlobeNewswire)
Jan-06-25 06:30AM	Hyperscale Data Subsidiary, Alliance Cloud Services, Signs Multi-Year Agreement in Support of an Artificial Intelligence Implementation Within its Michigan Data Center (GlobeNewswire) +5.13%
Jan-02-25 04:30PM	Ault and Company, Inc. Announces Abandonment of Dutch Tender Offer to Acquire Shares of Common Stock of Hyperscale Data, Inc. (GlobeNewswire) +8.76%
04:30PM	Ault & Company, Inc. Announces Abandonment of Dutch Tender Offer to Acquire Shares of Common Stock of Hyperscale Data, Inc. (GlobeNewswire)
Dec-26-24 06:30AM	Hyperscale Data Completes $50 Million of the Aggregate $75 Million Preferred Equity Investment from Ault and Company (GlobeNewswire)
06:30AM	Hyperscale Data Completes $50 Million of the Aggregate $75 Million Preferred Equity Investment from Ault & Company (GlobeNewswire)
Dec-23-24 04:45PM	Hyperscale Data, Inc. Announces Notice of Noncompliance with NYSE American Listing Standards (GlobeNewswire)
06:30AM	Hyperscale Data Enters into an Agreement for a Financing of up to $25 Million (GlobeNewswire)
Dec-20-24 06:30AM	Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (GlobeNewswire)
Dec-16-24 06:30AM	Hyperscale Data Sells St. Petersburg Development Property for $13 Million (GlobeNewswire) -5.68%
Dec-09-24 06:30AM	Hyperscale Data Issues Business Update to Stockholders (GlobeNewswire)
Dec-06-24 06:30AM	Ault and Company, Inc. Announces Its Intention to Commence a Dutch Tender Offer to Acquire Approximately 111,000 Shares of Common Stock (Representing 10% of the Outstanding Common Stock) of Hyperscale Data, Inc. (GlobeNewswire) +35.94%
06:30AM	Ault & Company, Inc. Announces Its Intention to Commence a Dutch Tender Offer to Acquire Approximately 111,000 Shares of Common Stock (Representing 10% of the Outstanding Common Stock) of Hyperscale Data, Inc. (GlobeNewswire)
06:30AM	Loading…
Dec-02-24 06:30AM	Hyperscale Data Announces Business Update for TurnOnGreen (GlobeNewswire) -8.15%
Nov-29-24 06:30AM	Hyperscale Data Announces 640 Bitcoin Mined Year to Date (GlobeNewswire) -6.36%
Nov-27-24 06:40AM	Hyperscale Data issues special dividend of Series F Exchangeable Preferred Stock (TipRanks) +9.28%
Nov-26-24 06:30AM	Hyperscale Data Announces a Special Dividend of Series F Exchangeable Preferred Stock (GlobeNewswire) -11.95%
Nov-19-24 06:30AM	Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (GlobeNewswire) -8.12%
Nov-15-24 06:30AM	Hyperscale Data Announces a Special Dividend of Class B Common Stock (GlobeNewswire)
Nov-13-24 06:30AM	Hyperscale Data Announces a Special Dividend of 10% Series E Cumulative Redeemable Perpetual Preferred Stock (GlobeNewswire)
Nov-11-24 06:30AM	Hyperscale Data Announces Date and Ratio of Reverse Stock Split (GlobeNewswire)
Nov-07-24 06:40AM	Hyperscale Data plans to issue special one-time dividend (TipRanks) +5.05%
06:30AM	Hyperscale Data to Launch Bitcoin Mining Pilot in the Gulf of Mexico with Oil and Gas Producer (GlobeNewswire)
Nov-06-24 06:30AM	Hyperscale Data Plans to Issue a $16.25 Million Stated Value Special Dividend of 10% Series E Cumulative Redeemable Perpetual Preferred Stock (GlobeNewswire) +10.92%
Oct-21-24 06:30AM	Hyperscale Data Announces Twenty-Eight Consecutive Monthly Cash Dividend Payments Timely Paid for Series D Preferred Stock (GlobeNewswire)
Jun-18-24 06:30AM	Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (Business Wire) +12.37%
Jun-11-24 06:30AM	Ault Alliance Announces Twenty-Four Consecutive Monthly Cash Dividend Payments Timely Paid for Series D Preferred Stock (Business Wire)
Jun-03-24 06:30AM	Ault Alliance Announces Plans to Issue a Special Preferred Artificial Intelligence Data Center and Bitcoin Mining Dividend to Stockholders (Business Wire)
May-21-24 06:30AM	Ault Alliance Achieves Profitability in the First Quarter of 2024; Revenue Increases by 55% to $45 Million (Business Wire) +19.93%
May-17-24 04:30PM	Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (Business Wire) +10.25%
06:30AM	Ault Alliances Subsidiary, Sentinum, Announces 89 Bitcoin Mined in April 2024 (Business Wire)
May-10-24 06:30AM	Ault Alliances Subsidiary, Sentinum, Announces 89 Bitcoin Mined in April 2024 (Business Wire) -5.39%
May-08-24 06:30AM	Ault Alliances Subsidiary, Sentinum, Completes Initial Bitcoin Mining Installation at Montana Location (Business Wire)
May-03-24 06:30AM	Ault Alliance Completes Final Distribution of TOG Securities (Business Wire)
May-02-24 06:30AM	Ault Alliance Regains Compliance with NYSE American Continued Listing Standards (Business Wire) +12.94%
Apr-29-24 06:30AM	Ault Alliance Reports Preliminary Revenue of $36 Million for First Quarter 2024 (Business Wire)
Apr-26-24 06:30AM	Ault Alliance No Longer Seeking to Sell Midwest Hotel Portfolio (Business Wire)
Apr-25-24 06:30AM	Ault Alliances Subsidiary, Sentinum, Announces Signing of First Non-Mining Related Colocation/Hosting Agreement (Business Wire) -6.69%
Apr-19-24 06:30AM	Ault Alliance Has Received an Investment of $44 Million to Date from Ault & Company under the November 2023 Securities Purchase Agreement (Business Wire) +25.57%
Apr-18-24 06:30AM	Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (Business Wire) -7.70%
Apr-17-24 06:30AM	Ault Alliance Announces Strong Performance from its Global Defense and Electronics Subsidiary Gresham Worldwide (Business Wire) -9.11%
Apr-16-24 06:30AM	Ault Alliance Announces a Final Distribution of TOG Securities Valued at $0.0141 for Each Share of Ault Alliance Common Stock (Business Wire)
Apr-03-24 06:30AM	Ault Alliances Subsidiary, Sentinum, Announces 105 Bitcoin Mined in March 2024, Generating a Monthly Mining Operations Run Rate of Approximately $6.8 Million (Business Wire)
Mar-22-24 09:51AM	Ault Alliance Announces a Final Distribution of TOG Securities Valued at Approximately $0.019 for Each Share of Ault Alliance Common Stock (Business Wire)
06:30AM	Ault Alliances Subsidiary, Sentinum, Announces Its Montana Bitcoin Mining Site will be Operational and Mining by the End of March 2024 (Business Wire)
Mar-20-24 06:30AM	Ault Alliance Issues Letter to Stockholders (Business Wire)
Mar-19-24 09:00AM	Ault Alliance Announces New Telemedicine Initiative at GuyCare (Business Wire) -7.52%
Mar-18-24 04:30PM	Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (Business Wire) -7.49%
Mar-13-24 09:00AM	Ault Alliance Announces Termination of At-The-Market Offering and Embarks on Path to Corporate Restructuring (Business Wire) +22.56%
Mar-12-24 06:30AM	Ault Alliances Subsidiary, Sentinum, Announces 103 Bitcoin Mined in February 2024, Achieving Record Monthly Run Rate of Approximately $7.4 Million (Business Wire) -12.18%
Feb-27-24 06:30AM	Ault Alliance Announces Record Preliminary 2023 Revenue of $153 Million, up 30% from 2022 (Business Wire) +19.06%
Feb-23-24 09:00AM	Ault Alliances Sentinum Planning Major Expansion at Its Michigan and Montana Data Centers, Including up to 300 Megawatts Capacity in Michigan (Business Wire) -5.99%
Feb-16-24 06:30AM	Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (Business Wire)
Feb-13-24 10:05AM	Ault Alliance Anticipates Utilizing Previously Authorized Common Stock Repurchase Plan (Business Wire) +25.45%
Feb-07-24 06:30AM	Ault Alliance Does Not Intend to Consummate Any Acquisitions as It Focuses on Maximizing the Value of Its Existing Assets (Business Wire) +14.78%
Feb-05-24 06:30AM	Ault Alliances Subsidiary, Sentinum, Announces 121 Bitcoin Mined in January 2024 (Business Wire) -14.02%
Jan-31-24 06:30AM	Ault Alliance Issues Letter to Stockholders (Business Wire) -10.52%
Jan-24-24 06:30AM	Ault Alliance Issues Letter to Stockholders Summarizing Current Operations and Future Outlook (Business Wire)
Jan-18-24 06:30AM	Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (Business Wire) -10.50%
Jan-12-24 04:30PM	Ault Alliance Announces Results of Annual Meeting of Stockholders (Business Wire) -22.90%
Jan-10-24 06:30AM	Ault Alliance to Begin Holding Bitcoin on Its Balance Sheet, Marking Change in Financial Strategy (Business Wire)
Jan-09-24 08:15PM	Ault Alliance Announces the Removal of Certain Proposals to Be Voted upon at Its Annual Meeting of Stockholders and the Reduction in the Percentage Required to Obtain Quorum (Business Wire) -8.98%
06:30AM	Ault Alliance Returns to Treasury Common and Preferred Stock, Enhancing Financial Stability (Business Wire)
Jan-05-24 05:25PM	Ault Alliance Announces Postponement of Commencement of Exchange Offer of Common Stock for Series D Preferred Shares (Business Wire)
Jan-04-24 06:30AM	Ault Alliances Subsidiary, Sentinum, Announces 151 Bitcoin Mined in December 2023, Achieving Record Monthly Run Rate of Approximately $6.5 Million (Business Wire)
Dec-29-23 06:30AM	Ault Alliance, Inc. Announces Adjournment of Its Annual Meeting of Stockholders (Business Wire) -5.75%
Dec-28-23 06:30AM	Ault Alliance Subsidiary, RiskOn International, to Announce Its New Generative AI Platform and Technology Partner on January 3, 2024 (Business Wire) -9.82%
Dec-27-23 06:30AM	Ault Alliance Subsidiary Files Lawsuit Against Singing Machine CEO Gary Atkinson and Other Directors Who Approved Highly Dilutive Related Party Stock Sale (Business Wire) +11.11%
Dec-26-23 06:30AM	Ault Alliance Sets 2024 Revenue Goals at $230-$240 Million (Business Wire) +21.03%
Dec-21-23 06:30AM	Ault Alliance Provides Additional Information on Exchange Offer of Common Stock for Series D Preferred Shares at an Effective Price of $0.25 per Share of Common Stock Exchanged (Business Wire)
Dec-19-23 06:30AM	Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (Business Wire)
Dec-18-23 06:30AM	Ault Alliance Announces Gresham Worldwide Defense Business Projects over $50 Million in Annual Revenue for 2024 Amid Strong Demand from Israel and Europe (Business Wire)
Dec-15-23 06:30AM	Ault Alliance Receives an Investment of $41.5 Million from Ault & Company (Business Wire) -7.39%
Dec-13-23 06:45AM	Ault Alliance Reiterates Its Intention to Commence an Exchange Offer of Common Stock for Series D Preferred Shares at an Effective Price of $0.25 per Share of Common Stock Exchanged (Business Wire) +9.64%
Dec-06-23 06:30AM	Ault Alliances Subsidiary, Sentinum, Announces 133 Bitcoin Mined in November 2023 with a Current Annual Run Rate of $70.1 Million (Business Wire)
Dec-04-23 06:30AM	Ault Alliances Subsidiary, Sentinum, Set to Launch New Montana Data Center, Boosting Bitcoin Mining Operations (Business Wire) +9.93%
Dec-01-23 06:30AM	Ault Alliance Announces That TurnOnGreens Common Stock is Now Quoted on OTC Link ATS Under the Symbol IMHC (Business Wire)
Nov-30-23 06:30AM	Ault Alliance Announces that Its Indirect Subsidiary, MTIX, Ltd. Provides Substantial Cost Savings and Environmental Benefits From Using Its Proprietary MLSE Process (Business Wire)
Nov-29-23 09:00AM	Ault Alliance Announces Its Intention to Commence an Exchange Offer to Acquire Shares of Its Common Stock for up to $15 Million in Series D Preferred Shares (an Effective Price of $0.25 per Share of Common Stock Exchanged) (Business Wire) +10.84%
Nov-27-23 06:30AM	Ault Alliance Issues Letter to Stockholders Summarizing Third Quarter Financial Results and Updating on Capital Raising and Business Focus (Business Wire)
Nov-17-23 05:00PM	Ault Alliance Announces Notice of Noncompliance with NYSE American Listing Standards (Business Wire) -5.05%
06:30AM	Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock (Business Wire)
Nov-16-23 06:30AM	Ault Alliances Subsidiary, Sentinum, Announces that It Is Ready to Accept up to 40 Artificial Intelligence Clusters with Nvidia and AMD GPUs at Its Michigan Data Center and Future Expansion Plans (Business Wire) +8.30%

Hyperscale Data, Inc. owns and manages a data center, and provides mission-critical products for the defense and aerospace, industrial, automotive, telecommunications, medical and biopharma, and textile industries. It operates through the following segments: GWW, TurnOnGreen, Ault Alliance, Crypto-Currency, Real Estate, Ault Disruptive, and Holding Company. The GWW segment offers defense solutions. The TurnOnGreen segment includes commercial electronics solutions. The Ault Alliance segment is involved in commercial lending, activist investing, media, and digital learning. The Crypto-Currency segment includes crypto mining operations. The Real Estate segment consists of hotel operations and other commercial real estate holdings. The Ault Disruptive segment refers to a special purpose acquisition company. The company was founded by Milton C. Ault III in 1969 and is headquartered in Las Vegas, NV.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Horne William B.	Chief Executive Officer	Dec 30 '24	Sale	5.21	2	10	0	Jan 02 06:00 AM
AULT MILTON C III	Executive Chairman	Dec 20 '24	Buy	5.48	400	2,193	7,949	Dec 23 06:45 PM
AULT MILTON C III	Executive Chairman	Dec 16 '24	Buy	7.18	300	2,153	7,349	Dec 18 04:30 PM
AULT MILTON C III	Executive Chairman	Dec 17 '24	Buy	6.43	200	1,286	7,549	Dec 18 04:30 PM
AULT MILTON C III	Executive Chairman	Dec 11 '24	Buy	7.25	200	1,451	7,049	Dec 13 04:30 PM
AULT MILTON C III	Executive Chairman	Dec 05 '24	Buy	5.25	500	2,625	6,849	Dec 09 04:30 PM
AULT MILTON C III	Executive Chairman	Dec 03 '24	Buy	5.87	200	1,174	6,149	Dec 05 04:30 PM
AULT MILTON C III	Executive Chairman	Dec 04 '24	Buy	5.50	200	1,100	6,349	Dec 05 04:30 PM
AULT MILTON C III	Executive Chairman	Nov 27 '24	Buy	6.36	100	636	5,949	Dec 02 04:30 PM
AULT MILTON C III	Executive Chairman	Nov 20 '24	Buy	0.16	3,485	565	15,130	Nov 22 09:30 PM
AULT MILTON C III	Executive Chairman	Sep 30 '24	Buy	0.23	50,000	11,320	204,729	Oct 01 06:35 PM
AULT MILTON C III	Executive Chairman	Sep 24 '24	Buy	0.22	22,000	4,915	154,729	Sep 26 05:30 PM
AULT MILTON C III	Executive Chairman	Sep 18 '24	Buy	0.23	10,000	2,255	132,729	Sep 20 04:30 PM
AULT MILTON C III	Executive Chairman	Sep 13 '24	Buy	0.23	5,000	1,130	122,729	Sep 17 04:30 PM
AULT MILTON C III	Executive Chairman	Sep 10 '24	Buy	0.22	12,500	2,742	107,729	Sep 12 06:00 PM
AULT MILTON C III	Executive Chairman	Sep 11 '24	Buy	0.21	10,000	2,055	117,729	Sep 12 06:00 PM
AULT MILTON C III	Executive Chairman	Sep 11 '24	Buy	13.69	6	82	116	Sep 12 06:00 PM
AULT MILTON C III	Executive Chairman	Sep 09 '24	Buy	0.21	5,000	1,062	95,229	Sep 10 07:30 PM
AULT MILTON C III	Executive Chairman	Sep 06 '24	Buy	0.22	100	22	11,645	Sep 10 07:30 PM
Ault Alliance, Inc.	10% Owner	Sep 09 '24	Proposed Sale	0.74	866,654	641,324		Sep 09 06:00 AM
AULT MILTON C III	Executive Chairman	Aug 30 '24	Buy	0.20	10,000	2,046	90,229	Sep 05 04:30 PM
AULT MILTON C III	Executive Chairman	Aug 28 '24	Buy	0.23	45,000	10,354	70,229	Aug 30 04:30 PM
AULT MILTON C III	Executive Chairman	Aug 29 '24	Buy	0.21	10,000	2,083	80,229	Aug 30 04:30 PM
AULT MILTON C III	Executive Chairman	Aug 27 '24	Buy	0.23	1,500	344	11,545	Aug 30 04:30 PM
AULT MILTON C III	Executive Chairman	Aug 26 '24	Buy	0.23	2,500	576	10,145	Aug 27 04:30 PM
AULT MILTON C III	Executive Chairman	Aug 23 '24	Buy	0.23	1,300	303	7,645	Aug 27 04:30 PM
AULT MILTON C III	Executive Chairman	Aug 21 '24	Buy	0.23	2,300	539	5,845	Aug 23 05:30 PM
AULT MILTON C III	Executive Chairman	Aug 22 '24	Buy	0.23	500	116	6,345	Aug 23 05:30 PM
AULT MILTON C III	Executive Chairman	Aug 20 '24	Buy	0.25	800	196	3,545	Aug 21 08:35 PM
AULT MILTON C III	Executive Chairman	Aug 19 '24	Buy	0.23	500	117	2,745	Aug 21 08:35 PM
Ault Alliance, Inc.	10% Owner	Jun 24 '24	Buy	0.13	5,000	673	20,000	Jun 26 07:30 PM
Ault Alliance, Inc.	10% Owner	Jun 25 '24	Buy	0.13	5,000	630	25,000	Jun 26 07:30 PM
AULT MILTON C III	Executive Chairman	Jun 17 '24	Buy	0.28	10,000	2,790	25,229	Jun 20 04:30 PM
AULT MILTON C III	Executive Chairman	May 22 '24	Buy	0.39	15,000	5,874	15,229	May 24 04:30 PM
AULT MILTON C III	Executive Chairman	May 22 '24	Buy	0.39	1,983	765	2,245	May 24 04:30 PM

ALZN

Alzamend Neuro Inc

GPUS

Hyperscale Data Inc

Upgrade your FINVIZ experience